190 related articles for article (PubMed ID: 11705449)
1. Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2).
Feoktistov I; Garland EM; Goldstein AE; Zeng D; Belardinelli L; Wells JN; Biaggioni I
Biochem Pharmacol; 2001 Nov; 62(9):1163-73. PubMed ID: 11705449
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
Linden J; Thai T; Figler H; Jin X; Robeva AS
Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952
[TBL] [Abstract][Full Text] [Related]
3. Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation.
Grant MB; Davis MI; Caballero S; Feoktistov I; Biaggioni I; Belardinelli L
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2068-73. PubMed ID: 11481274
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.
Feoktistov I; Biaggioni I
J Clin Invest; 1995 Oct; 96(4):1979-86. PubMed ID: 7560091
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
Feoktistov I; Biaggioni I
Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573
[TBL] [Abstract][Full Text] [Related]
6. Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma.
Ryzhov S; Goldstein AE; Matafonov A; Zeng D; Biaggioni I; Feoktistov I
J Immunol; 2004 Jun; 172(12):7726-33. PubMed ID: 15187156
[TBL] [Abstract][Full Text] [Related]
7. Adenosine induces cyclic-AMP formation and inhibits endothelin-1 production/secretion in guinea-pig tracheal epithelial cells through A(2B) adenosine receptors.
Pelletier S; Dubé J; Villeneuve A; Gobeil F; Bernier SG; Battistini B; Guillemette G; Sirois P
Br J Pharmacol; 2000 Jan; 129(2):243-50. PubMed ID: 10694229
[TBL] [Abstract][Full Text] [Related]
8. Medicinal chemistry and pharmacology of A2B adenosine receptors.
Volpini R; Costanzi S; Vittori S; Cristalli G; Klotz KN
Curr Top Med Chem; 2003; 3(4):427-43. PubMed ID: 12570760
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
Peakman MC; Hill SJ
Br J Pharmacol; 1994 Jan; 111(1):191-8. PubMed ID: 8012696
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells.
Olanrewaju HA; Qin W; Feoktistov I; Scemama JL; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H650-6. PubMed ID: 10924064
[TBL] [Abstract][Full Text] [Related]
11. A2A and A3 receptors mediate the adenosine-induced relaxation in spontaneously active possum duodenum in vitro.
Woods CM; Toouli J; Saccone GT
Br J Pharmacol; 2003 Apr; 138(7):1333-9. PubMed ID: 12711634
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptor antagonists and retinal neovascularization in vivo.
Mino RP; Spoerri PE; Caballero S; Player D; Belardinelli L; Biaggioni I; Grant MB
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3320-4. PubMed ID: 11726639
[TBL] [Abstract][Full Text] [Related]
13. Role of adenosine in asthma.
Feoktistov I; Biaggioni I
Drug Dev Res; 1996; 39():333-6. PubMed ID: 11542498
[TBL] [Abstract][Full Text] [Related]
14. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
Kim YC; Ji X; Melman N; Linden J; Jacobson KA
J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749
[TBL] [Abstract][Full Text] [Related]
15. A new chemical tool (C0036E08) supports the role of adenosine A(2B) receptors in mediating human mast cell activation.
Buceta M; Domínguez E; Castro M; Brea J; Alvarez D; Barcala J; Valdés L; Alvarez-Calderón P; Domínguez F; Vidal B; Díaz JL; Miralpeix M; Beleta J; Cadavid MI; Loza MI
Biochem Pharmacol; 2008 Oct; 76(7):912-21. PubMed ID: 18687311
[TBL] [Abstract][Full Text] [Related]
16. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
17. Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
Phelps PT; Anthes JC; Correll CC
Eur J Pharmacol; 2006 Apr; 536(1-2):28-37. PubMed ID: 16581066
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A₁ and A(2B) adenosine receptors.
Yip KH; Lau HY; Wise H
Br J Pharmacol; 2011 Sep; 164(2b):807-19. PubMed ID: 21506953
[TBL] [Abstract][Full Text] [Related]
19. A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.
Alexander SP; Losinski A; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Jan; 111(1):185-90. PubMed ID: 8012695
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Kim SA; Marshall MA; Melman N; Kim HS; Müller CE; Linden J; Jacobson KA
J Med Chem; 2002 May; 45(11):2131-8. PubMed ID: 12014951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
